Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |